Cadence Solutions, Inc. — Valuation, Funding & Investors

Cadence Solutions, founded in 2021, provides always-on, AI-enabled remote care for people living with chronic disease. Its Clinical Intelligence platform tracks vitals, symptoms, medications and engagement, flagging risk early so clinicians can act before a crisis, and the company partners with hospital systems to monitor patients, coach them and titrate medications between visits.

Cadence is trusted by more than 20 health systems and has served a population of more than 100,000 patients through deep EMR integrations. The company has been recognized by TIME as one of the Top 100 HealthTech Companies and by LinkedIn as a Top Startup, ranking fourth in 2025.

Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Cadence Solutions, Inc..

Often trade at a premium or discount to NAV.

Platforms match existing holders with buyers. Cadence Solutions, Inc. availability at any moment is set by the holders.

High minimums, transfer approval, company right-of-first-refusal.

Valuations, rounds and IPO status for every company in the directory — Cadence Solutions, Inc. included.

The closest digital health / remote patient monitoring and chronic disease management peers are on the competitors page.

The routes section explains what is realistically available for a company at this stage.

No. Cadence Solutions, Inc. is a private company; its shares do not trade on a public exchange.

The last valuation is $1.2B (post-money, Jun 2026).

Lead investors for each round are in the funding timeline.